We are live on ! Find out more
CE

Clark Estates Portfolio holdings

AUM $430M Turnover 31.13%
1-Year Est. Return 9.71%
This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+9.71%
3 Year Est. Return
+47.82%
5 Year Est. Return
+44.64%
10 Year Est. Return
+195.24%
AUM
$607M
AUM Growth
+$16.8M
Cap. Flow
-$9.1M
Cap. Flow %
-1.5%
Top 10 Hldgs %
52.23%
Holding
95
New
7
Increased
14
Reduced
15
Closed
7
Avg Time Held
1.9 years
Top 10 Avg Time Held
1.1 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
SOLV icon
Solventum
SOLV
+$10.1M
2
SNN icon
Smith & Nephew
SNN
+$4.12M
3
AGCO icon
AGCO
AGCO
+$3.68M
4
HAL icon
Halliburton
HAL
+$3.49M
5
TAP icon
Molson Coors Class B
TAP
+$3.34M

Top Sells

Rank Stock Value
1
GEHC icon
GE HealthCare
GEHC
+$8.32M
2
FISV icon
Fiserv
FISV
+$6.55M
3
ZBH icon
Zimmer Biomet
ZBH
+$6.08M
4
DELL icon
Dell
DELL
+$4.67M
5
OVV icon
Ovintiv
OVV
+$3.95M

Sector Composition

Rank Sector Weight
1 Healthcare 25.34%
2 Miscellaneous 19.21%
3 Consumer Staples 14.54%
4 Technology 12.86%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ECML icon
1
Euclidean Fundamental Value ETF
ECML
$118M
$116M 19.07%
3,363,441
+12,600
+0.4% +$398K
2023 Q2
3 quarters
KVUE icon
2
DELISTED
Kenvue
KVUE
$26.8M 4.42%
1,250,000
+150,000
+14% +$3.05M
2023 Q3
2 quarters
DNB icon
3
DELISTED
Dun & Bradstreet
DNB
$25M 4.12%
2,491,000
+100,000
+4% +$1.09M
2022 Q4
5 quarters
PM icon
4
Philip Morris
PM
$291B
$22.9M 3.78%
250,300
+15,000
+6% +$1.38M
2019 Q4
17 quarters
HLN icon
5
Haleon
HLN
$39.8B
$22.5M 3.71%
2,650,000
– –
2022 Q3
6 quarters
MDT icon
6
Medtronic
MDT
$129B
$22.2M 3.66%
255,000
-30,000
-11% -$2.56M
2022 Q1
8 quarters
FISV icon
7
Fiserv
FISV
$30.6B
$20.8M 3.43%
130,300
-45,000
-26% -$6.55M
2022 Q1
8 quarters
GEHC icon
8
GE HealthCare
GEHC
$37.1B
$20.5M 3.37%
225,000
-100,000
-31% -$8.32M
2022 Q4
5 quarters
SNN icon
9
Smith & Nephew
SNN
$12.5B
$20.3M 3.34%
800,000
+150,000
+23% +$4.12M
2023 Q1
4 quarters
LHX icon
10
L3Harris
LHX
$48B
$20.3M 3.34%
95,075
-5,000
-5% -$1.05M
2023 Q2
3 quarters
UL icon
11
Unilever
UL
$136B
$20.1M 3.31%
355,556
– –
2021 Q4
9 quarters
STTK icon
12
Shattuck Labs
STTK
$460M
$13.2M 2.17%
1,475,648
– –
2020 Q4
13 quarters
BLCO icon
13
Bausch + Lomb
BLCO
$7.44B
$10.7M 1.76%
617,500
+65,500
+12% +$1.02M
2022 Q3
6 quarters
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$3.45T
$10M 1.65%
66,420
-10,000
-13% -$1.43M
2018 Q1
24 quarters
SOLV icon
15
Solventum
SOLV
$14.5B
$9.39M 1.55%
+135,000
New +$10.1M
2024 Q1
0 quarters
DDD icon
16
3D Systems
DDD
$270M
$6.3M 1.04%
1,418,614
– –
2013 Q2
43 quarters
CROX icon
17
Crocs
CROX
$7.32B
$4.83M 0.8%
33,600
– –
2022 Q1
8 quarters
GTES icon
18
Gates Industrial
GTES
$6.1B
$4.53M 0.75%
256,000
– –
2023 Q4
1 quarter
QCOM icon
19
Qualcomm
QCOM
$176B
$4.44M 0.73%
26,200
– –
2023 Q2
3 quarters
AYI icon
20
Acuity Inc
AYI
$9.6B
$4.43M 0.73%
16,500
-1,000
-6% -$242K
2023 Q4
1 quarter
CI icon
21
Cigna
CI
$72.3B
$4.36M 0.72%
12,000
– –
2023 Q2
3 quarters
SLVM icon
22
Sylvamo
SLVM
$1.45B
$4.32M 0.71%
70,000
– –
2023 Q1
4 quarters
HOG icon
23
Harley-Davidson
HOG
$3.31B
$4.13M 0.68%
94,500
– –
2023 Q3
2 quarters
WLY icon
24
John Wiley & Sons Class A
WLY
$2.45B
$4.1M 0.68%
107,500
+17,500
+19% +$599K
2023 Q3
2 quarters
AMWD icon
25
DELISTED
American Woodmark
AMWD
$4.07M 0.67%
40,000
– –
2023 Q3
2 quarters

Similar funds

Clark Estates's Q1 2024 Portfolio in Review

As of Q1 2024, Clark Estates held 95 positions worth $607M, up 2.8% from $590M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Clark Estates's Q1 2024 filing shows 7 new, 14 increased, 15 reduced and 7 closed positions. Its largest new stake was Solventum: 135,000 shares worth $9.39M. The largest sale was GE HealthCare, an estimated $8.32M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 26% a quarter earlier, followed by Miscellaneous and Consumer Staples.

  • Clark Estates's largest Q1 2024 buy was Solventum: 135,000 shares worth $9.39M.
  • Clark Estates added most to Smith & Nephew in Q1 2024, an estimated $4.12M increase.
  • Clark Estates's biggest Q1 2024 reduction was GE HealthCare, cutting an estimated $8.32M.
  • Clark Estates fully exited Zimmer Biomet in Q1 2024, selling an estimated $6.08M.
  • Clark Estates's ten largest holdings make up 52% of its $607M portfolio in Q1 2024.
  • Clark Estates opened 7 new positions and closed 7 in Q1 2024.
  • Clark Estates's portfolio value rose 2.8% quarter-over-quarter to $607M.

Based on Clark Estates's 13F filing for Q1 2024, filed 7 May 2024.